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ABSTRACT
Objectives: Although the transition to secondary
progressive multiple sclerosis (SPMS) is known to be
a period of uncertainty for clinicians, who may find
progressive disease challenging to objectively identify,
little research has explored the experiences of patients
and carers specifically during this transition period.
Our objective was to explore what patients and their
carers understand about their disease stage and
describe their experiences and perspectives on the
transition to SPMS.
Design: Semistructured qualitative interviews and
subsequent validation focus groups were analysed
using inductive thematic analysis.
Setting: South East Wales, UK.
Participants: 20 patients with MS and 13 carers were
interviewed. Eight patients and two carers participated
in focus groups.
Results: Four main themes around disease
progression were identified. ‘Realisation’ describes how
patients came to understand they had SPMS while
‘reaction’ describes their response to this realisation.
The ‘realities’ of living with SPMS, including dealing
with the healthcare system during this period, were
described along with ‘future challenges’ envisaged by
patients and carers.
Conclusions: Awareness that the transition to SPMS
has occurred, and subsequent emotional reactions and
coping strategies, varied widely between patients and
their carers. The process of diagnosing the transition
was often not transparent and some individuals wanted
information to help them understand what the
transition to SPMS meant for them.
INTRODUCTION
Multiple sclerosis (MS) is the most common
disabling neurological condition affecting
young adults.1 Most people with relapsing
onset MS, which is the commonest form at
diagnosis, will subsequently develop secondary-
progressive MS (SPMS) at some point in their
disease.1 Relapsing MS is characterised by a
lack of disease progression during the periods
between relapses. When the level of disability
begins to increase independently of relapses,
MS is termed secondary-progressive.2 Little is
known about the healthcare experiences of
people with MS (pwMS) at the onset of sec-
ondary progression,3 despite its vital import-
ance as a milestone of future disability
evolution,4 disease pathology and treatment
options.5 Previous studies have examined spe-
ciﬁc support and information needs of pwMS
at diagnosis and times of treatment selection,6 7
and have also explored general support needs
of pwMS and their carers occurring through-
out the disease course.8–11
Clinicians have described the patient’s
experience of receiving conﬁrmation of the
onset of SPMS as similar to ‘being diagnosed
again’,(ref. 12, p.460) and also recognise the
clinical challenge they face in objectively
identifying transition to SPMS in individual
patients.13 In part this is because of genuine
diagnostic uncertainty as a result of the
subtlety of signs of early progressive disease
Strengths and limitations of this study
▪ The study describes the experience of transition-
ing to secondary progressive multiple sclerosis
(SPMS) from the perspectives of people with MS
and carers, which little previous research has
focused on.
▪ Widely varying responses to this transition have
been identified and explored.
▪ This study may help health professionals provide
better support during the transition to SPMS by
improving their understanding of how patients
and carers experience this phase of the disease.
▪ All the participants live in one area so some of
their experiences may be specific to their local
context. Further research with people living in
different areas and utilising different healthcare
systems would be useful.
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that on average lasts nearly 3 years.14 The lack of avail-
able evidence-based treatments for SPMS means that
identiﬁcation of disease progression may lead to the dis-
continuation of disease modifying agents.15 In turn, the
frequency of neurology team contacts may decrease,
potentially creating a feeling of abandonment16 at a
time when pwMS are coming to terms with having a pro-
gressive disease, facing declining mobility and experien-
cing difﬁculties with maintaining normal work and
social activities.17
In this study, we aimed to explore the experiences of
pwMS of transition from relapsing onset MS to SPMS
and to document views of carers during this period. We
contend that transition to SPMS is likely to generate
novel and speciﬁc support needs for both pwMS and
their carers. We hoped to identify ways in which the pro-
vision of information and support could be improved to
help professionals understand the speciﬁc needs of
pwMS and carers at this stage and provide insights for
those involved in service planning.
METHODS
Our research was funded by the MS Trust, with a view to
increasing knowledge of patient and carer support
needs around the transition to SPMS. A qualitative
design was chosen as it was apparent that what was ini-
tially required was a deeper understanding of the issues
from the perspectives of patients and carers. The meth-
odology was based on social constructionism, which
emphasises that the meaning and experience of illness is
socially constructed, based on how individuals come to
understand and live with their illness, and how illnesses
are shaped by cultural and social factors.18
Setting and recruitment
The project was approved by South East Scotland
Research Ethics Committee 01 (REC reference: 13/SS/
0160). PwMS from three university health board areas in
South Wales (Aneurin Bevan, Cardiff and Vale, and
Cwm Taf) were identiﬁed using an extensive, well-
validated clinical database held at the University
Hospital of Wales, Cardiff, UK, which has been
described previously.19 In all three areas all of the pwMS
had access to a specialist MS nurse and could contact
their MS team when required through a telephone
helpline.
Participant selection
The inclusion criteria for pwMS were: (1) aged over
18 years, (2) diagnosed with MS with an Expanded
Disability Status Scale (EDSS) score of between 4 and 8
recorded by a clinician in the previous year, (3) able to
give informed consent, (4) does not have primary pro-
gressive MS. A purposive sampling strategy was used to
identify pwMS close to the transition, and people with
established SPMS who had recently experienced the
transition. An MS specialist nurse (RJ) used the clinical
information recorded on the database together with
clinical judgement in advising which pwMS were most
likely to be close to transition to SPMS, and also con-
ﬁrmed there were no known concerns or capacity issues
relating to the invitation to participate. Seventy-four
pwMS who met the inclusion criteria were sent postal
invitations including written study information by the
neurology team, aiming to recruit 20–30 participants.
Carer participants were approached via the pwMS using
snowball sampling techniques. When pwMS and carers
returned expressions of interest forms by post the
researcher (FD) made contact with the participants via
telephone or email. Some carers were identiﬁed as
being interested in participation and recruited oppor-
tunistically by the researcher while attending another
prearranged interview. All participants provided written
informed consent prior to participation.
Data collection
A semistructured interview guide using core questions
with optional prompts was designed (see box 1). The
guide was informed by existing literature from studies
on: living with long-term conditions, health literacy and
self-management as well as from discussion among the
Box 1 Interview guide summary (amendments for carer
questions shown in brackets)
A. Current experience of multiple sclerosis (MS)
How does your MS affect you (your friend/relative) day to
day at the moment?
What do you find most bothersome?
(What do you think they find most bothersome? What do
you find most bothersome?)
B. Sources of information and support
What support have you been offered to help you cope with
your MS up to now (to help you cope with caring for
someone with MS)?
What was the most useful thing about the support you were
given?
How do you think support for patients (carers of people)
with MS could be improved?
Where do you go to find information about how to manage
MS?
Is there anything that you think stops people with MS
(carers) from getting the support they need?
C. Changing support needs
What do you understand about the stage of MS that you are
(your friend or relative is) at, at the moment?
If the person with MS (carer) specifically mentions transi-
tion or having secondary-progressive MS explore what
finding this out meant to them and what sort of support
they wanted at that time
As time has gone on, has the sort of support you have
needed changed?
How would you like to receive support and information
about MS?
Do you have any particular concerns about the future and
how you will get the support you might need?
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authors and patient representatives. No substantial
changes were made following the pilot interview with a
patient representative, although minor changes to the
wording of some questions were suggested. The inter-
views took place at the participants preferred locations.
Data were reviewed after 17 patient interviews and 10
carer interviews had been conducted, at which point
data saturation was evident and no new themes were
emerging from newly collected data.20 Three additional
patient interviews and three additional carer interviews
were conducted to ensure that we had satisﬁed the
requirement of data saturation at which point it was
decided that interviewing could conclude. A standar-
dised questionnaire was used to collect demographic
information following the interviews. Questions on
current walking ability (previously validated as an esti-
mate of EDSS21) and perception of current MS disease
stage were included. Date of diagnosis and most recent
clinician EDSS score were obtained, with consent, from
the patients’ medical records.
Respondent data validation
Following initial analysis of the interview data, two focus
groups were held to allow emerging concepts to be
reported to participants for validation.22 Key issues
raised during the patient and carer interviews were
fed-back to the focus group participants. Using a group
approach can help participants explore their views
about norms of experience about a topic that might not
be accessible in a one-to-one setting.23 The focus groups
acted to validate the interview ﬁndings, to further reﬁne
the key themes and as an opportunity to explore new
issues related to future service provision. All participants
from the interview stage who had indicated interest in
focus group attendance were invited.
Analysis
All interviews and focus groups were audio recorded and
transcribed verbatim. An inductive thematic analysis of
the interview transcripts was undertaken as described by
Braun and Clarke.24 FD and FW independently read and
made notes on four interview transcripts each. A code-
book was generated through joint discussion and all tran-
scripts were coded by FD using the software NVivo V.10
(QSR International). When new codes were generated
inductively, the codebook was reﬁned, and the reﬁne-
ments documented within the NVivo software as new
topics emerged. Once all interview transcripts were
coded FD began the process of identifying candidate
themes which were then discussed with FW. The focus
group data were coded using early candidate themes
from the interview data and the themes were subse-
quently further reﬁned. The full data set was then
reviewed by FD to ensure the candidate themes were rep-
resentative and the themes were named collaboratively
(FD and FW). Again this process was logged in NVivo
which served as an audit trail for our data analysis.
RESULTS
Sample characteristics
Participant characteristics are summarised in tables
1–3. Twenty-two pwMS expressed initial interest in the
study (subsequently two withdrew: one due to health
problems, one due to scheduling difﬁculties). Nine
carers were identiﬁed by pwMS and interviews
arranged. Four carers were identiﬁed by the researcher
and recruited opportunistically. A total of 20 patients
and 13 carers were interviewed by FD (an academic
general practitioner (GP) with training in qualitative
research). Eighteen pwMS and nine carers were inter-
viewed individually. An additional two pwMS and four
carers requested that their interviews were conducted
jointly. Interviews were conducted at the participants’
preferred locations, usually at their own home or the
home of their relative (N=27). Three participants
were interviewed on hospital premises to coincide with
an appointment, two were interviewed at their work-
places and one participant was interviewed at a coffee
shop.
Three pwMS and one carer attended the ﬁrst focus
group. Five pwMS and one carer attended the second
Table 1 Participant demographics
Characteristics
Patients
(total sample
size 20)
Carers
(total sample
size 14*)
Sex
Female 15 6
Male 5 8
Age (years)
31–40 4 1
41–50 7 2
51–60 5 5
61–70 4 4
71–80 0 2
Level of education
No formal qualifications 0 6
Some qualifications up
to O-level or equivalent
6 2
A-levels or equivalent 2 2
University level or
above
12 4
Employment status
Employed FT 2 2
Employed PT 2 1
Employed
(on long-term sick)
1 0
Unemployed—looking
for work
1 1
Out of the labour force
not seeking work
9 2
Retired early 2 2
Retired due to age 3 5
Full-time carer 0 1
*One carer only attended a focus group.
FT, full time; PT, part time.
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focus group (the one carer had not taken part in the
interview phase). Both groups were held in a community
meeting venue. FD led the focus groups and FW acted
as assistant moderator—keeping notes of the discussion
and ensuring that all topics had been appropriately
covered. The semistructured interviews took between 27
and 75 min. The focus groups lasted 79 and 88 min,
respectively. None of the participants were known to the
researchers before study start.
Key themes
When discussing disease progression, four themes
emerged: Realisation, Reaction, Reality and Recognising
Future Challenges. The codebook and a table mapping
the original codes to the key themes are provided in
online supplementary appendix 1. Illustrative quotations
for each theme are included in table 4. Although the
data from pwMS and carers were initially explored inde-
pendently, there was signiﬁcant overlap between the
data sets so a combined analysis was undertaken to
derive the ﬁnal themes. Issues which were more unique
to each group were also evident and this is discussed
where relevant.
Realisation—finding out about the transition
Some pwMS reported a gradual realisation of entering
the secondary progressive phase. These people were
often already aware that secondary progression could
occur and started to identify their own increasing disabil-
ity. In these situations discussion of the transition with
professionals acted to conﬁrm the suspicions of the
pwMS. Although some pwMS were happy coming to a
gradual realisation, others expressed frustration that the
conversation was not initiated by their neurologist. In
some cases, when health professionals brought up SPMS
it was unexpected, while several participants only discov-
ered the label by chance (such as through an overheard
conversation or when sent a copy of the clinic letter
written to their GP). When the news came as a surprise
for pwMS, the confusion was heightened by a lack of
understanding about how the diagnosis had been
reached.
Preferences for when and how pwMS would have liked
to have found out they had SPMS were closely linked to
the signiﬁcance they attributed to the label. PwMS and
carers suggested that when SPMS was conﬁrmed, pwMS
needed an explanation of how SPMS was identiﬁed.
They also wanted to know what having SPMS meant for
them, what they should or could do for themselves and
what the MS team could do to support them.
Face-to-face discussion of the issue was generally pre-
ferred with written information seen as a useful adjunct.
Some participants preferred to source information in
their own time and recognised that early in the transi-
tion phase feelings of denial might be a barrier to
absorbing information.
The ‘realisation’ theme was less evident in the carer
data. Carers often found recognising a gradual deterior-
ation in the person they cared for challenging. Carers
usually relied heavily on the information that the pwMS
gave them about their current stage.
Reaction—what secondary progressive disease means
The meaning attributed to transitioning to SPMS varied
widely between pwMS. For some pwMS, SPMS was seen
as just a label, which in itself had little relevance to the
day-to-day reality of living with MS. Some pwMS were
not interested in how clinicians chose to label their MS
as whichever label was applied they believed their
future prognosis remained difﬁcult to accurately
predict. Others were troubled by the fact that SPMS
limited the treatment options available to them and
that nothing could be done to inﬂuence subsequent
progression. The discussion about reaching SPMS was
often accompanied by the news that pwMS would no
Table 3 Carer relationship and duration of caring role
Time as a carer (years) Carers, n (total 14)
1–10 8
11–20 5
>21 1
Relationship to person with MS
Spouse/partner 8
Parent 4
Sibling 1
Close friend 1
MS, multiple sclerosis.
Table 2 MS duration, level of disability and current
disease-modifying agent use of participants with MS
Time since MS
diagnosis (years)
Patients,
n (total 20)
1–10 7
11–20 10
>21 3
Patient estimated EDSS at interview
<4 1
5 3
5.5 1
6 6
6.5 4
7 4
7.5 1
Most recent clinician rated EDSS (within 1 year)
4 2
4.5 1
5.5 1
6 7
6.5 8
7.5 1
Currently receiving disease-modifying agent
Yes 4
No 16
EDSS, Expanded Disability Status Scale; MS, multiple sclerosis.
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Table 4 Themes, components and illustrative quotations
Themes Components Illustrative quotations
Realisation Method of finding out P016: The neurologist said to me, “You do realise you’re secondary progressive,”
and I said “Yeah I’ve worked that one out”
P010: When he [GP] was on the telephone to the clinic saying you know “got a
patient whose been diagnosed with secondary”, that’s how I found out about it
only hearing him on the phone. Nobody said to me you’ve got secondary
progressive
P008: I knew over time because I couldn’t walk as far as I used to, just slowed
down a bit, so I knew it was sort of happening, yeah, so I was well aware of it really
Understanding of how
the diagnosis is made
P044: I know there’s no definitive, for anyone there’s no specific test that they
can do but yes it would be nice to know well okay why, or what do you determine
or what do you look at in a person to then decide what MS they now have?
Reaction Response to the news P005: It’s devastating, it’s like you’re grieving, you’re grieving for what you’ve lost.
P030: I first of all, I panicked. (INT: Did you?)
And I thought to myself “Oh my God, it’s one of the worse ones”, but it isn’t, I
know that now, cos I was bawling, I thought “Oh my God, I’m gonna die from it”
The meaning of SPMS P024: Natural part of the disease, I didn’t have a negative thought upon it, I didn’t
sit down and cry or anything. Just take it as what it is, can’t do anything else
unfortunately
P023: It means that my chance of disease modifying therapy is limited
Reality—living
with progressive
disease
Symptoms P006: Mobility was always a problem. It now is much more of a problem.
P020: Some days tiredness overwhelms me
Loss of independence C031: Some things that she’ll say to me don’t make sense, when she’s talking I
think “Why did you say that?”
P038: My wife has to prepare food for me, has to prepare drinks for me because
I can’t do it
P005: I can’t get where I want to go and do what I want to do
Limitations on social
life
C039: We don’t go out as much as we’d like together.
P036: I don’t go out anymore I’d rather stay in. Because the later you get in the
day and then getting more sluggish, I’m hurting more and I’ve got constant pain
in my eyes and I find I can’t handle it and by 9 o’clock I’m in bed
Change in identity P004: I do miss going to work because I’ve always worked and it’s a bit strange
not to go to work, and I do, I did find it hard to, well, to know what to do
P018: I would honestly love to have a different life so I could be there for my
grandchildren
Supporting oneself C045: We follow the press and the media and get the MS Society journals and
everything. So for instance we will be following up the news that there might be a
drug for secondary progressive sufferers available
Support from others P012: Twice a week I go to yoga with a lot of people who also have MS. And it’s
nice to speak and see all those people and they’re very supportive and that sort
of makes life a bit easier [….] it’s some sort of support and you can ask other
people for ideas about things and then sharing the information which helps.
Reality—
healthcare
experiences
around
transition
Healthcare
experiences
P013: I walk up and down the corridor for so many minutes and they watch that
and then I don’t understand what I’m meant to do with that when I go home
P020: You know your appointment is quite limited so you are not there to have a
counselling appointment are you? You are there to be told if you need medication
or I don’t know, I think, yes, I suppose in a way you are just left to get on with it in
some ways
C028: We only tend to ring her [MS nurse] when it’s important. We appreciate
how busy she is and how understaffed they are but I’d say this; when she does
come back to you, she gives you 100%
P022: I think that when you are first diagnosed you get a lot of help, afterwards
you just get left alone, nobody does anything and you have to keep going on and
on saying I want this, I want this
C027: He [GP] (laughs) tells me that I’ve got to zip my mouth when I go in there
if I go in there with him [son], I’m not allowed to say anything. I will, if I see him
struggling to answer a question, I will, I will sort of, er … (C028: Prompt him).
C027:… prompt him or tell the doctor what is happening, but they don’t like it
Continued
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longer be offered follow-up by a neurologist. This was
interpreted by some as disinterest from the medical pro-
fession and led to a sense of abandonment as it
appeared care had been ‘down-graded’. Some pwMS
described with frustration that they felt professional
support and information provision was more focused on
the earlier stages of the disease. In others, the conﬁrm-
ation of SPMS triggered a signiﬁcant emotional reac-
tion; concerns that deterioration might be imminent
and periods of denial were described. Transitioning to
SPMS could prompt the ﬁnal realisation that things
were not going to improve, which could trigger feelings
of loss around their former status and future plans.
PwMS described that during the earlier phases of the
disease they were still able to get on with life as normal
during periods of remission, but when progression
occurred the pervasive effects of MS could no longer be
ignored. While many described a profound and nega-
tive emotional reaction to the life changes occurring
during the transition, others described reaching SPMS
as further motivation to try to ﬁght the disease and
maintain some level of control.
Similar to the realisation theme, the reaction theme
was represented less within the carer data. Some carers
explained what they perceived the impact to have been
on the pwMS, but for the carers themselves the label of
SPMS often had little personal signiﬁcance.
Reality—living with progressive disease
PwMS and carers described multiple physical and cogni-
tive symptoms of MS. Declining mobility had a major
impact on daily life, restricting independence. The more
invisible symptoms including fatigue, pain, low mood,
cognitive problems and personality changes were even
more difﬁcult for some to cope with. Although cognitive
issues were recognised by the pwMS they were often par-
ticularly challenging for the carers to deal with. Carers
were sometimes unsure whether symptoms could deﬁn-
itely be attributed to MS and could ﬁnd the subtle cog-
nitive changes in pwMS confusing. Many participants
recognised that it was the knock-on effect that one
symptom could have on others, for example, fatigue
impacting on mobility and cognition, together with
symptom unpredictability and individual variability that
made MS particularly difﬁcult to manage.
Simple daily activities had become difﬁcult for some
and in general carers described taking on an increased
number of domestic chores. Disease progression often
meant pwMS could no longer partake in the activities
that had previously deﬁned their identity, in the work-
place and socially. This frequently led to a re-evaluation
of personal identity. Leaving the workplace, described by
one person with MS as ‘like losing your arm’ (P022)
appeared particularly difﬁcult for those who placed
great importance on working. Others described the
inability to fulﬁl family and household roles difﬁcult to
accept. Both pwMS and carers recognised how their
social lives had become limited. Some recognised that
accepting that they needed assistance could make their
lives easier and had adapted to their changing disability
by modifying activities or taking up new enjoyable roles.
Keeping active physically and socially was important to
most pwMS, who were highly motivated to do what they
could. Keeping informed about MS also appeared to
help some pwMS and carers to feel they were doing
something active to support themselves. PwMS and
carers described the role of their families and friends,
employers, peer support and wider societal attitudes in
helping them to deal with the reality of disease
progression.
Reality—healthcare experiences around transition
Many participants could not understand the infrequency
of planned healthcare contacts in view of the signiﬁcant
impact MS had on their lives. Many felt a lack of
funding limited service provision and worried about
future funding cuts. There was frustration that the
health and social care systems did not always actively
promote the services available and that it was necessary
to be ‘pushy’.
Expectations of appointments with the MS team
varied, from simply having someone to talk to, to getting
a ‘progress report’ on their MS and treatment informa-
tion. PwMS often felt time pressured within their
appointments and those who were frustrated with their
healthcare experiences found services were not tailored
Table 4 Continued
Themes Components Illustrative quotations
Recognising
future
challenges
Living with uncertainty C017: It’s like living your life with a weight on your back all the time, we can’t do,
we can’t plan anything
Hoping for
maintenance
P018: Well with the future I try not to think about it. I do think “Oh God, I just want
to be able to walk.”
Hoping for
improvement/cure
P024: All I want is the MS cure, but when is that going to happen? I don’t think it
would be in my lifetime
The carer relationship P002: You can’t tell them [carers] everything and they often sit there and worry
and then don’t like to start asking about things, just in case they upset us and…
P025: It’s very difficult
C, carer; GP, general practitioner; MS, multiple sclerosis; P, person with MS.
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to their own information needs and preferences. PwMS
described how sometimes they felt appointments were
too focused on addressing the agenda of the profes-
sional they saw (eg, to carry out physical examinations
and update their records). In these circumstances,
pwMS struggled to understand what they were sup-
posed to gain from attendance. Some pwMS took lists
to their appointments to ensure their own agenda was
addressed.
Continuity of care helped patients to feel well sup-
ported. Conﬁdence in their healthcare professionals
evolved over time as positive past experiences reassured
pwMS and carers that the healthcare system would
provide any future support they might need. Although
GPs could provide continuity, many did not expect their
GP to be an expert in MS and preferred to utilise spe-
cialist teams. A few participants raised concerns about
‘bothering’ healthcare professionals, often taking steps
to try to support themselves before seeking help. Carers
often attended review appointments, some seeing this as
a useful opportunity to have their own questions
answered while others attended primarily to support to
the pwMS. Many carers felt they had useful information
they could provide during appointments and wanted to
feel that their contribution was valued although this was
often not their experience. In general carers were less
likely to use health professionals as part of their own
support network. They valued the health professionals
for how they could support the pwMS, and often if the
pwMS were adequately supported this had a positive
impact on carers. Carers had rarely been offered
support for themselves and several commented on the
fact the research interview was their ﬁrst ever opportun-
ity to formally discuss their caring responsibilities.
Recognising future challenges—hopes for the future
Different strategies were used by pwMS and carers in
dealing with the uncertainty associated with the progres-
sion of MS. Some avoided thinking about the future
describing it as futile, given the unpredictable clinical
course of MS. However, the burden of trying to live with
this unpredictability was recognised. Some participants
were able to reﬂect on the ways in which they had suc-
cessfully overcome challenges in the past to gain conﬁ-
dence in their ability to do the same in the future.
Deterioration in their own condition was the main
concern described by pwMS, whereas carers worried
about how the person with MS would cope with declin-
ing function and how they would cope themselves. Some
pwMS and carers expressed discomfort in the evolution
of the role of the carer, while others saw caring as a duty
they were obliged and happy to take on. The difﬁculties
of discussing MS between pwMS and carers were recog-
nised with both parties fearing causing upset.
Participants recognised that neither the person with MS
nor the carer really had a full understanding of how the
situation was impacting on the other, compounded by a
lack of communication. Carers were keen that in the
face of increasing disability they did what they could to
maintain what independence was possible for the pwMS.
However, some felt conﬂicted about balancing this
desire with trying to protect the person, also expressing
concerns about being overprotective. Many pwMS
hoped to be able to maintain their current level of func-
tion; some hoped to beneﬁt from a future cure while
others described this as a more distant aspiration.
DISCUSSION
Our participants with MS came to know that they had
SPMS in a variety of ways, from gradual personal realisa-
tion to a medical decision the basis of which was hard to
understand. Some pwMS learned they had SPMS without
any advanced knowledge or understanding of what
SPMS meant for them which sometimes caused confu-
sion and upset. In other cases the medical labelling of
the transition seemed to occur after the patient had
already accepted disease progression and so was of little
consequence. PwMS and carers described the reality of
living with MS on a daily basis with its associated physical,
social and psychological impact. Efforts were made to
maintain hope while facing an uncertain future.
The current study examines a stage of the disease
recognised by clinicians as being challenging for profes-
sionals and patients alike, and provides evidence of the
experience of transitioning to SPMS for pwMS and
carers, which to date has not been well described. The
participants were varied in terms of age and duration of
experience with MS. Varied experiences of the transition
itself have been identiﬁed and described. The profes-
sional background of our research team, which included
specialist MS health professionals, academic GPs and
social scientists has helped to ensure that any particular
professional biases that may have emerged throughout
the analysis have been discussed and challenged during
data analysis discussions. The participants all lived in
one geographical area so some of their experiences may
relate to the organisation of the local healthcare system.
Many participants were older and out of the work force
(and so more likely to have available time to participate
in research) and although some were younger and in
work, the challenges for this group may not have been
fully explored. The carer group tended to be older,
including some parent carers, perhaps reﬂecting that
younger carers who may be working full time may not
identify with the carer label. We also recognise that
carers were not well represented in the focus groups. As
the regional clinical database employed by the specialist
team does not record ‘in transition’ as a disease stage it
was difﬁcult to identify patients most suitable for inclu-
sion, and some of the participants felt they had transi-
tioned some years ago. Consequently for those people
we were relying on retrospective accounts which may
have been inﬂuenced by subsequent experiences.
The experience of living with MS described by
patients in this study is well understood and previously
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similarly described. Living with uncertainty, and experi-
encing denial and a sense of loss of identity are known
to be important challenges experienced by many, while
some also describe being able to reach acceptance and
maintain hope.17 25–29 We believe this study highlights
that, for some, the transition to SPMS may be a particu-
lar ‘fear-point’ (ref. 30, p.18) in the disease course, trig-
gering a signiﬁcant emotional reaction and generating a
need for additional support.
Those patients with more positive experiences of the
realisation and reaction phases tended to be those with
the knowledge required to interpret the transition to
SPMS for themselves. Anticipatory preparation can
facilitate patients’ personal transitions, but in order
to prepare patients require knowledge about what to
expect and what strategies they might ﬁnd helpful.31
Patients cannot engage with the process of a transition,
by for example seeking out information and proactively
modifying activities, if they do not recognise a transi-
tion is occurring.31 PwMS have expressed a desire for
two-way communication with their health professionals
and wish to feel they are working in partnership
together.30 32 Previous research showed that pwMS did
not want information to be ‘sugar-coated’30 and felt
betrayed or patronised if they believed clinicians had
chosen to withhold information. Too much information
was generally seen as better than not enough.30
Although knowledge has been noted to have an import-
ant role in decreasing fear in MS27 gaps have been
identiﬁed, here and elsewhere between the level of
information patients desire and the amount profes-
sionals actually provide.10 33
Like those oncology patients also experiencing a tran-
sition in their condition and care34 some of our partici-
pants, described feeling abandoned and unclear about
future options. Clinicians may try to spare their patients
from diagnostic uncertainty and uncomfortable knowl-
edge35 and feel reluctant to reveal difﬁcult diagnoses
and prognoses.36 37 This may partly explain why so few
of our participants described transition discussions as
being initiated by their neurologist. Clinicians tend to be
reluctant to disclose an upsetting diagnosis that has little
beneﬁt for the patient37 though they are more likely to
consider formalising the diagnosis if they perceive
potential gain.38 Doctors who are uncomfortable with
discussing transitions may use ambiguous language,
provide incomplete information and minimise the sig-
niﬁcance of results.39 Communication skills training for
clinicians discussing these transitions of care has previ-
ously proven beneﬁcial,40 41 and the introduction of
similar training for neurologists has been suggested.42
This could facilitate an exchange of relevant information
and potentially avoid situations we have described where
pwMS feel neurologists are not interested in SPMS, and
see SPMS is a ‘demotion’ in the potential future
outcome and the quality of expected care. Clearer com-
munication, around the rationale for nurse-led follow-up
in particular, might help alleviate the concerns some
participants expressed about no longer being reviewed
by a neurologist.
Being confronted with disease progression prompted
signiﬁcant emotional reactions among some of our parti-
cipants. PwMS are keen to see improvements in the
availability of psychological support, which they recog-
nised as an important deﬁcit in available services.11 12 17
Participants described employing differing coping strat-
egies during the transition phase. A chosen coping strat-
egy may be helpful or unhelpful depending on the
situation.43 Although denial and unrealistic optimism
may initially help people to deal with the stress of their
changing circumstances, in the long term, failure to
acknowledge emotions may leave them unresolved.45 46
Emotions need to be expressed and processed over time
in order to facilitate adjustment44 which may require
social and professional support. Soundy et al28 described
how people who had reached acceptance of their MS
diagnosis and prognosis expressed hope through being
positive, accessing support and taking each day as it
comes. Our participants described utilising self-
management strategies, and participation in self-
management is known to promote good adjustment.44
Health professionals can capitalise on this interest in
self-management by facilitating access to appropriate
information and engagement in physical and social
activity.
The stages that carers may pass through in their
acceptance of support have been described as rejecting,
resisting, seeking and accepting support.46 Most carers
in our study appeared to be in the ﬁrst two stages and
many seemed able to cope independently. The lack of
previous discussion with professionals around their own
well-being suggested that until carers are carrying out
the physical tasks of caring, their own support needs can
be easily overlooked, compounded by the fact that
carers themselves may reject support.
Further research that deﬁnes objective markers of the
transition to SPMS would be extremely useful for clini-
cians and their patients. The current tendency not to
conﬁrm SPMS until it is certain may make identifying
patients at the transition stage for future research chal-
lenging. Observation of clinical encounters may be
useful to conﬁrm objectively what occurs when the tran-
sition is discussed and to identify areas for improvement.
CONCLUSION
Awareness that the transition to SPMS is occurring or
has occurred, and subsequent emotional reactions and
coping strategies, vary widely between pwMS and their
carers. PwMS and carers want to know what SPMS
means for them and what they could be doing to help
themselves. If health professionals can provide these
explanations, pwMS may feel empowered to self-manage
while feeling conﬁdent that health professionals will
form part of a supportive network for the future.
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